Myriad Genetics Shares Climb After Angelina Jolie Has Mastectomy
Cancer test developer Myriad Genetics (MYGN) saw its shares climb 4% Tuesday, a move that followed word from actress Angelina Jolie that she had a double mastectomy after learning she was at high risk for breast cancer. Jolie wrote in … Continue reading →